Chief Financial Officer Kevin Rubin sold 1,682 shares of Zscaler common stock on March 17, 2026, at $156.5932 per share, creating gross proceeds of $263,389. The sale took place while the shares were trading near a 52-week low of $140.56 and after the stock had fallen 47% over the preceding six months.
A Form 4 filed with the Securities and Exchange Commission shows the disposal was executed to satisfy tax withholding requirements triggered by the vesting of restricted stock units. After the sale, Rubin directly holds 46,479 Zscaler shares.
Company performance and valuation notes
Alongside the insider transaction, Zscaler disclosed a strong second quarter for fiscal 2026, with revenue up 26% year over year and annual recurring revenue rising 25%. The company cited robust contributions from its Data Security, AI, and Zero Trust Exchange product areas. Zscaler also said it plans to expand its data sovereignty capabilities with a deployment in Canada as part of an infrastructure footprint that includes 160 data centers.
Some market tools and analyses indicate Zscaler may be undervalued, with Fair Value estimates and financial health metrics available through InvestingPro providing additional context for investors evaluating the stock.
Analyst reactions
Analyst firms offered a range of responses to Zscaler's recent updates and results. Wells Fargo initiated coverage with an Overweight rating and set a $200 price target. TD Cowen reduced its price target to $220 from $260 while keeping its rating unchanged and signaling concerns about market contraction. BMO Capital lowered its price target to $210 from $315 and simultaneously raised its fiscal 2026 annual recurring revenue estimate by $32 million, attributing that increase largely to inorganic growth. Stifel kept a Buy rating but revised its price target to $180 from $320, noting the company’s quarterly results exceeded guidance and consensus estimates.
Context and takeaway
The insider sale by the CFO was disclosed as a tax-related action linked to RSU vesting, and it coincided with a period in which the stock has traded well below recent highs. Meanwhile, corporate results showed continued revenue and ARR expansion, and analyst views on valuation and forward prospects varied significantly across firms.